Kline Kyle's Form 4 filing
Globus Medical Inc (GMED) · filed Jan 12, 2026
- Accession no.
- 0001193125-26-010699
- Filed
- Jan 12, 2026
- Trade date
- Jan 8, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $363.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kline KyleCIK 0002080625 | Officer (Senior Vice President, CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Class A Common Stock | MOption exerciseAcquired | +3,594 | $51.87 | +$186,420.78 | 3,594 | Direct | |
| Jan 8, 2026 | Class A Common Stock | SSaleDisposed | −3,594 | $101.10 | −$363,353.4 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 8, 2026 | Class A Common Stock | MOption exerciseDisposed | −3,594 | $0.00 | $0 | 3,906 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.